Metraipolis › archive › dc_cd80d364c5e4
What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An… — Europe PMC PMID:42732142
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42732142
- DOI
- 10.12688/wellcomeopenres.26466.2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T16:35:09.706Z
- SHA-256 of the archived text
93241bff2f4467686a4be2ed8cc663badf50f5d0c4b194b24eda00237b948c1f- Stable URL of this page
https://metraipolis.com/documento/dc_cd80d364c5e4
How to cite
What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An… — Europe PMC PMID:42732142 — Europe PMC (en), https://europepmc.org/article/MED/42732142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd80d364c5e4 (Metraipolis archive dc_cd80d364c5e4, sha256 93241bff2f4467686a4be2ed8cc663badf50f5d0c4b194b24eda00237b948c1f)
BibTeX
@misc{dccd80d364c5e4,
title = {What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An… — Europe PMC PMID:42732142},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42732142},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd80d364c5e4; sha256 93241bff2f4467686a4be2ed8cc663badf50f5d0c4b194b24eda00237b948c1f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42732142. Agents can read the archived copy with the MCP tool read_document.